UnitedHealth Group Inc. Earnings: Can They Grow Despite Obamacare?

Investors have been enthusiastic about UnitedHealth's prospects, but will the health-insurance giant deliver?

Apr 15, 2014 at 2:30PM

On Thursday, UnitedHealth Group (NYSE:UNH) will release its quarterly report, and investors have anticipated solid results from the health-insurance company by bidding its share to new all-time highs in recent weeks. Yet even as UnitedHealth and rivals WellPoint (NYSE:ANTM) and Humana (NYSE:HUM) have struggled to deal with and incorporate the health-care reforms under Obamacare into their respective business models, UnitedHealth hopes to find new avenues for growth in areas that WellPoint and Humana have largely left untapped.

Investors have been nervous about the impact of Obamacare on health-insurance companies for years, figuring that the requirement that UnitedHealth Group and its peers accept patients with pre-existing conditions would require a massive hit to earnings. Now that the individual mandate has taken effect, the question for UnitedHealth is whether greater numbers of enrollees will make up for the negative impact of higher losses from those who used to be relegated to high-risk pools and other backwaters of the insurance industry. Let's take an early look at what's been happening with UnitedHealth Group over the past quarter and what we're likely to see in its report.

Source: TaxFix.co.uk, Flickr.

Stats on UnitedHealth Group

Analyst EPS Estimate


Change From Year-Ago EPS


Revenue Estimate

$32.03 billion

Change From Year-Ago Revenue


Earnings Beats in Past 4 Quarters


Source: Yahoo! Finance.

Which way will UnitedHealth Group earnings move?
In recent months, analysts have had negative views on UnitedHealth earnings, cutting their first-quarter estimates by a dime per share and making similar reductions to their 2015 full-year projections. The stock, though, has done well, rising 4% since early January.

UnitedHealth Group's fourth-quarter earnings report showed the tale of two businesses that are driving the health-insurance giant's results. Overall, UnitedHealth's revenue rose 8% on membership growth of 170,000 people, and net earnings jumped 18% from the year-ago quarter. Although its traditional insurance business did reasonably well, UnitedHealth Group's biggest growth came from its Optum health-care services division, which enjoyed a 35% gain in sales that came largely from a boost in pharmacy-services revenue.

Yet Obamacare has been a wildcard for UnitedHealth Group and the entire health-insurance industry. WellPoint took an aggressive stance on health-care insurance exchanges, while UnitedHealth Group and some of its peers were more conservative about waiting to see how the exchanges played out. Now that the individual mandate has taken effect, analysts are still uncertain whether the actual mix of new enrollees under Obamacare will lead to greater profits or greater losses for UnitedHealth and other insurance companies. Some demographic studies have found that a relatively small number of Obamacare participants actually lacked insurance coverage prior to enrolling, with gains in employer-sponsored insurance and Medicaid enrollment being offset by millions of previously insured Americans losing their previous coverage.

Another big challenge for UnitedHealth Group could come from Medicare Advantage, where reimbursement rates are under constant threat. Still, UnitedHealth has maintained a relatively modest exposure to Medicare Advantage compared to Humana, which gets more than two-thirds of its earnings from the government program. Moreover, favorable indications that reimbursement rates for Medicare Advantage might not drop as much as had originally been feared led to a brief pop for UnitedHealth and Humana in late February, proving that volatility related to government-program revenue can work both ways.

Still, UnitedHealth Group is seeking to maximize all of its growth opportunities. Its pharmacy benefit management business handles $30 billion in operations, and UnitedHealth's decision in 2011 to bring that business in-house has opened the door to potentially huge profit growth. At the same time, UnitedHealth Group's foray oversees to buy Brazilian insurer Amil two years ago gives UnitedHealth some diversification from the risks involved in its U.S. operations.

In the UnitedHealth Group earnings report, watch to see how Obamacare affects the health insurer's first-quarter results. With full implementation just now taking effect, it'll be interesting to see whether the long-anticipated benefits to Obamacare outweigh the costs that UnitedHealth Group has to bear under the program.

3 stocks poised to be multi-baggers
The one sure way to get wealthy is to invest in a groundbreaking company that goes on to dominate a multibillion-dollar industry. Our analysts have found multi-bagger stocks time and again. And now they think they've done it again with three stock picks that they believe could generate the same type of phenomenal returns. They've revealed these picks in a new free report that you can download instantly by clicking here now.

Click here to add UnitedHealth Group to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group and WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information

Compare Brokers